

A look at pharma revenue rankings
Apr 26, 2024
This podcast delves into the annual pharma revenue rankings, highlighting the top 20 companies for 2023 and comparing with 2022. It discusses Johnson's top position, Novo Nordisk and Eli Lilly's growth, Novo Nordisk's exceptional performance with GLP1 drugs, market performance of drugs like Ozempic and Zepbound, revenue projections, and strategic moves within the top 20 list.
Chapters
Transcript
Episode notes